Our research facilities span imaging, computational biology, bioinformatics, genome sequencing and analysis, statistical genetics, chemistry, structural biology and drug discovery and high performance computing. This means, for example, we can identify new biological markers, pathways or influences, determine function and structure, leading to drug design and evaluation. As a result, we have spun out 11 companies, registered more than 66 patents, 104 provisional patents and 16 our licensing agreements.